zeinabafshar710@gmail.com,
fatemi_farahnaz@yahoo.com,
f.mohaghegh199@gmail.com.
We presented the first case of AGEP following treatment with
remdesivir in a patient with COVID-19 without hydroxychloroquine use
which could be an important issue when dealing with cutaneous rashes,
considering the widespread use of Remdesivir in COVID era.